Publication date: Dec 01, 2024
We present the case of a 13-year-old female diagnosed with juvenile systemic sclerosis, diffuse cutaneous subtype, along with active disseminated tuberculosis. This co-occurrence poses unique diagnostic and therapeutic challenges, particularly given the risk of tuberculosis exacerbation due to immunosuppressive therapy required for systemic sclerosis. The patient had signs/symptoms like progressive skin tightening and Raynaud’s phenomenon; the diagnosis was confirmed by the presence of anti-Scl-70 antibodies. Concurrently, active disseminated tuberculosis was identified by a cartridge-based nucleic acid amplification test (CBNAAT) and supported by high-resolution computed tomography (HRCT) thorax and fine needle aspiration cytology (FNAC) of the submandibular lymph node. Treatment involved anti-tuberculosis therapy prior to initiating immunosuppression, ensuring a careful balance between managing autoimmunity and infection. The case emphasizes the importance of multidisciplinary collaboration and vigilant follow-up in managing complex autoimmune conditions coexisting with infectious diseases. Early diagnosis and an individualized approach were crucial to achieving clinical improvement in this adolescent pediatric patient.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Systemic Sclerosis |
disease | MESH | Tuberculosis |
pathway | KEGG | Tuberculosis |
disease | MESH | systemic sclerosis diffuse |
disease | IDO | nucleic acid |
disease | IDO | immunosuppression |
drug | DRUGBANK | Isoxaflutole |
disease | MESH | autoimmunity |
disease | MESH | infection |
disease | MESH | infectious diseases |
disease | MESH | autoimmune diseases |
disease | MESH | pulmonary tuberculosis |
disease | MESH | tuberculous lymphadenitis |